Literature DB >> 17766

Side effects and contraindications of beta-receptor blocking agents.

H Lydtin.   

Abstract

Unwanted effects of beta-receptor blocking agents can be divided into three categories: 1. Those arising specifically from the pharmacologic, i.e., beta-blocking action. 2. Side effects not directly (or not with certainty) related to beta-blockade. 3. Adverse and potentially specific reactions to individual beta-blocking agents. Category 1 covers the majority of adverse effects (heart failure, severe bradycardia and hypotension, arterial insufficiency, increased airways resistance, gastrointestinal symptoms, hypoglycemia). These can largely be avoided by proper selection and preparation of patients. Category 2 covers cutaneous reactions (rashes, alopecia, pruritus), purpura (thrombocytopenic and nonthrombocytopenic) etc. as well as side effects attributable to the central nervous system (antianxiety effects, nightmares etc.). In the third category the "oculo-cutaneous syndrome" associated with practolol is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 17766     DOI: 10.1007/BF01488578

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  130 in total

1.  Letter: Pericarditis and peritonitis associated with practolol therapy.

Authors:  D Hunt; J L Frew
Journal:  Br Med J       Date:  1975-01-11

2.  Dual adreoceptor-mediated control of noradrenaline secretion from human vasoconstrictor nerves: facilitation by BETA-receptors and inhibitor by alpha-receptors.

Authors:  L Stj-5aarne; J Brundin
Journal:  Acta Physiol Scand       Date:  1975-05

3.  Effects of propranolol on the hormonal and metabolic responses to insulin-induced hypoglycaemia.

Authors:  E A Abramson; R A Arky; K A Woeber
Journal:  Lancet       Date:  1966-12-24       Impact factor: 79.321

4.  Letter: Skin reactions to beta-blockers.

Authors:  J B Cumberbatch
Journal:  Br Med J       Date:  1974-11-30

5.  Proceedings: Inhibitory effect of propranolol on insulin secretion.

Authors:  B L Furman; F M Tayo
Journal:  Br J Pharmacol       Date:  1973-09       Impact factor: 8.739

Review 6.  Perspectives in adrenergic beta-receptor blockade.

Authors:  J D Fitzgerald
Journal:  Clin Pharmacol Ther       Date:  1969 May-Jun       Impact factor: 6.875

7.  Propranolol and quinidine in the management of ventricular tachycardia.

Authors:  L S Dreifus; H F Lim; Y Watanabe; E McKnight; M N Frank
Journal:  JAMA       Date:  1968-05-20       Impact factor: 56.272

8.  Effect of sotalol (MJ 1999) and propranolol on insulin-induced hypoglycemia in the rat.

Authors:  J H Brown; D A Riggilo
Journal:  Proc Soc Exp Biol Med       Date:  1968-04

9.  [Is Practolol (ICI-50172) a cardioselective beta-blockader?].

Authors:  K G Lanser; S Siemssen; V Sill
Journal:  Z Kardiol       Date:  1973-01

10.  Effect of beta-adrenergic blockade on resting and stimulated fat mobilization.

Authors:  E J Pinter; C J Pattee
Journal:  J Clin Endocrinol Metab       Date:  1967-10       Impact factor: 5.958

View more
  1 in total

Review 1.  COVID-19 infection and cardiac arrhythmias.

Authors:  Antonis S Manolis; Antonis A Manolis; Theodora A Manolis; Evdoxia J Apostolopoulos; Despoina Papatheou; Helen Melita
Journal:  Trends Cardiovasc Med       Date:  2020-08-16       Impact factor: 6.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.